Skip to main content
Clinical Trials/NCT03571425
NCT03571425
Completed
Not Applicable

The Impact of Enteral Versus Oral Protein Feeding on Muscle Protein Synthesis in Healthy Young Males and Females

University of Exeter1 site in 1 country30 target enrollmentJune 4, 2018
ConditionsHealthy

Overview

Phase
Not Applicable
Intervention
Not specified
Conditions
Healthy
Sponsor
University of Exeter
Enrollment
30
Locations
1
Primary Endpoint
Postprandial muscle protein synthesis
Status
Completed
Last Updated
7 years ago

Overview

Brief Summary

The present study will seek to quantify the muscle protein synthetic response to a protein beverage consumed orally or through a nasogastric tube in healthy, young individuals.

Detailed Description

Thirty healthy, young volunteers will receive a stable isotope tracer infusion (8.5h) combined with repeated blood and muscle sampling, in order to measure muscle protein synthesis rate in the postabsorptive state, and following oral placebo ingestion (n=10), oral protein ingestion (n=10), or enteral protein administration (n=10).

Registry
clinicaltrials.gov
Start Date
June 4, 2018
End Date
December 1, 2018
Last Updated
7 years ago
Study Type
Interventional
Study Design
Parallel
Sex
All

Investigators

Responsible Party
Sponsor

Eligibility Criteria

Inclusion Criteria

  • 18-40 years of age
  • Body mass index between 18.5 and 30

Exclusion Criteria

  • Any diagnosed metabolic impairment (e.g. type 1 or 2 Diabetes)
  • Any diagnosed cardiovascular disease
  • Elevated blood pressure at the time of screening. (An average systolic blood pressure reading of ≥140 mmHg over two or more measurements and an average diastolic blood pressure of ≥90 mmHg over two or more measurements)
  • Chronic use of any prescribed or over the counter pharmaceuticals (that may modulate muscle protein metabolism). This excludes oral contraceptives and contraceptive devices.
  • A personal or family history of epilepsy, seizures or schizophrenia.
  • Presence of an ulcer in the stomach or gut and/or strong history of indigestion
  • Known pre-existing liver disease/condition
  • Any known disorders in muscle metabolism
  • Regular use of nutritional supplements
  • Allergy to lidocaine

Outcomes

Primary Outcomes

Postprandial muscle protein synthesis

Time Frame: 5 hours

Muscle protein synthesis rate (FSR) following ingestion of a placebo or protein supplement

Secondary Outcomes

  • Postabsorptive muscle protein synthesis(2 hours)
  • Whole-body protein synthesis(7 hours)
  • Whole-body protein breakdown(7 hours)
  • Whole-body protein oxidation(7 hours)
  • Whole-body protein net balance(7 hours)
  • Gastric emptying rate(5 hours)
  • Blood glucose concentration(8.5 hours)
  • Serum insulin concentration(8.5 hours)

Study Sites (1)

Loading locations...

Similar Trials